What’s New in emma
- emma - Compact Systems Australia
- Dec 2, 2025
- 1 min read
Upcoming Release Highlights
Welcome to Compact's emma Newsletter. Moving forwards, ahead of every new release, emma users can now expect a newsletter outlining all of the new features and changes due for deployment in each upcoming release which can also be accessed on our website www.compactcare.com.au
Some of our users might have noticed some recent changes to our interface, which have largely arisen as a result upcoming requirements for full eNRMC conformance. We've been grateful for the extremely helpful feedback provided by many of our users during this time, and have been working away at improvements directly resulting from your feedback.
Here's what you can expect to from our release next Wednesday, 3rd December at 10pm (AEST):
Prescriptions:
Prescriber details will now be hidden by default, and expandable
Self-Administration has been moved to instructions and now defaults to off.
Strength field no longer blocks saving from database entries
Drug Schedules default to 'Unknown' if no schedule is pulled from the drug database
Formulations now provide dose units clearly alongside input fields.
The ePrescription section has been simplified to meet the Transitional eNRMC requirements
Patches:
The custom frequency issue has been fixed, so it no longer prevents processing.
Interface updated to display correctly on all tablet devices
PRN duplications removed for EMM users integrated with MyPak
Transdermal Patch application time bug resolved.
Thank you for your continued trust and feedback. We’re listening and committed to enhancing your experience.
The recent newsletter from Compact reveals a shift in interface features, signaling a response to user feedback which deserves scrutiny. While changes like hidden prescriber details and default settings aim to streamline usability, it raises questions about user autonomy and clarity. The incorporation of updates like those mentioned regarding Royal Reels www.nzartmonthly.co.nz might suggest a deeper strategy for compliance and user satisfaction.
The changes outlined in the newsletter seem to prioritize user experience, reflecting a responsive approach to feedback. However, it raises questions about the balance between interface simplicity and the functionality needed by users. For instance, while the new default settings could streamline use, they may not cater to all specific needs, especially for complex cases like https://australiangovernmentgrants.org/ Ricky's. This adaptation could lead to both improved usability and potential oversight of essential features.
The article presents a detailed overview of recent changes in the emma platform, reflecting a commitment to adapt based on user feedback. However, the approach to updates raises questions about how user-centric the development truly is. While improvements are welcomed, the emphasis on compliance, much like in the Online Casino Australia https://howtolaw.co/ context, suggests that regulatory pressures can often influence design more than user experience itself.
The changes outlined in the newsletter suggest a focused approach towards user experience, but one must consider the implications of such modifications. For instance, the decision to hide prescriber details by default raises questions about transparency. Moreover, the adjustments in Drug Schedules and self-administration protocols may impact user trust. Addressing user feedback is crucial, yet balancing security and usability remains a JackpoJjill https://dna-art.com/ challenge in software development.
It is evident that the structure is methodical across the full scope of the discussion. Assertions are grounded in observable facts. The website offers additional contextual materials related to the subject. User engagement flows are contextualized by interactive media services.